Connecting the Dots: Therapy-Induced Senescence and a Tumor-Suppressive Immune Microenvironment

Abstract

Senescent melanoma cells secret CCL5, which promotes recruitment of TILs. Combining TIS with immunotherapy that enhances tumor cell killing by TILs is a promising novel approach to improve melanoma outcomes.